News & blog

Investment company raises funds for life sciences

CHESTER-based investment manager Deepbridge Capital has announced the funding of four seed stage life sciences companies based in the North West.

A total of £575,000 will be invested across Widnes-based Aurio, Manchester-based eLucid mHealth and Renephra as well as Alderley Edge-based PeptiGelDesign.

Deepbridge raised £2m via the Deepbridge Life Sciences SEIS proposition, with an initial twelve companies now funded across the UK.

The Deepbridge Life Sciences SEIS provides financial advisers and private investors the opportunity to invest in a portfolio of early stage life sciences investments, whilst benefitting from the significant potential tax reliefs available via the Government’s Seed Enterprise. Read More